GOG 277: Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma Last updated on Apr 21, 2024 Previous GeDDiS: Gemcitabine and Docetaxel Versus Doxorubicin as First-Line Treatment in Advanced Soft-Tissue Sarcoma Next Sarcoma Trials
